Dr. Quick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
543 Taylor Ave
Columbus, OH 43203Phone+1 614-293-4969Fax+1 614-293-6111
Education & Training
- University of Vermont Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2006 - 2007
- University of Vermont Medical CenterResidency, Neurology, 2003 - 2006
- University of Vermont Medical CenterInternship, Internal Medicine, 2002 - 2003
- Indiana University School of MedicineClass of 2002
Certifications & Licensure
- OH State Medical License 2007 - 2026
- VT State Medical License 2002 - 2007
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 35 citationsRisk factors for amyotrophic lateral sclerosis: A regional United States case-control study.Angeline S. Andrew, Walter G. Bradley, Daniel Peipert, Tanya Butt, Kwadwo Amoako
Muscle & Nerve. 2021-01-01 - 10 citationsSafety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg
The Lancet. Neurology. 2021-10-01 - 246 citationsTrial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott
The New England Journal of Medicine. 2020-09-02
Press Mentions
- New $158K/year ALS Drug Raises Hope for MoreOctober 17th, 2022
- Radicava Hopes, Expectations from NFL’s William White and Doctors at Ohio StateAugust 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: